BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• 

  Bio NC

  ViiV Study Shows Investigational HIV Prevention Drug is 66% More Effective than Truvada

  ViiV Healthcare announced an injection of cabotegravir given every two months was 66% more effective at preventing HIV infection when compared to Gilead Sciences’ Truvada, according to the final analysis of the HPTN-083 study.

  July 8, 2020

   · 

  2 min read

   · 

  Alex Keown
• 

  Business

  Foghorn and Merck Ink Strategic Collaboration in Cancer for $425 Million+

  Foghorn Therapeutics entered into a strategic collaboration with Merck to leverage Foghorn’s Gene Traffic Control platform for cancer therapies.

  July 8, 2020

   · 

  3 min read

   · 

  Mark Terry
• 

  Sanofi Licenses Natural Killer Cancer Program from Kiadis in $987 Million Deal

  Kiadis Pharma, based in Amsterdam, The Netherlands, licensed a previously undisclosed K-NK0004 program to Paris-based Sanofi.

  July 8, 2020

   · 

  3 min read

   · 

  Mark Terry
• 

  Business

  A ‘Pan-Viral’ Vaccine Designed to Protect the Elderly from Known, and Unknown, Viruses

  What if you could get one vaccine that protects you against a wide spectrum of viruses, even viruses we haven’t discovered yet?

  July 8, 2020

   · 

  10 min read

   · 

  Chelsea Weidman Burke
• 

  Business

  Takeda Taps Twist Bioscience to Boost Biologics Discovery Capabilities

  Through the partnership, Takeda will have access to Twist’s “Library of Libraries,” a large phage display library created using precisely defined synthetic DNA sequences to discover unique antibodies to important therapeutic targets including GPCRs.

  July 8, 2020

   · 

  2 min read

   · 

  Alex Keown
• 

  Drug Development

  Evive Biotech Sees Positive Results in Phase III Trial for CIN in Breast Cancer Patients

  Evive Biotech announced today that its Phase III study investigating F-627 to treat chemotherapy-induced neutropenia (CIN) in breast cancer patients has met its primary and secondary endpoints.

  July 8, 2020

   · 

  3 min read

   · 

  Krystle Vermes
• 

  BioSpace Global Roundup, July 9

  Biopharma and life sciences companies from across the globe provide updates on their pipelines and businesses.

  July 8, 2020

   · 

  5 min read

   · 

  Alex Keown
• 

  Career Advice

  3 Ways the Biotech Industry Offers Work-Life Balance

  What factors do you think affect burnout? Do you think some industries are more prone to burnout than others?

  July 8, 2020

   · 

  3 min read

   · 

  Porschia Parker-Griffin
• 

  Business

  White House Begins Withdrawal from WHO as Opponents Seek to Reverse Decision

  On Tuesday, the White House notified Congress and the United Nations of the decision. However, the withdrawal will not be immediate.

  July 8, 2020

   · 

  3 min read

   · 

  Alex Keown
• 

  Policy

  Biogen Submits Aducanumab for Alzheimer’s Application to FDA

  The submission was completed with ongoing collaboration with the FDA and include data from the Phase III EMERGE and ENGAGE trials, as well as the Phase Ib PRIME study. Biogen has also requested Priority Review.

  July 8, 2020

   · 

  4 min read

   · 

  Mark Terry